Cigarette Smoking, and Blood Monocyte Count Correlate with Chronic Lung Injuries and Mortality

Abstract

Background Cigarette smoking (CS)-related monocytosis contributes to the development of chronic lung injuries via complex mechanisms. We aim to determine correlations between measures of CS and monocytes, their capacities to predict chronic lung diseases, and their associations with mortality. Methods A single-center retrospective study of patients undergoing surgical resection for suspected lung nodules/masses was performed. CS was quantified as cigarettes smoked per day (CPD), duration of smoking, composite pack years (CPY), current smoking status, and smoking cessation years. A multivariate logistic regression analysis was performed. Results Of 382 eligible patients, 88% were ever smokers. In this group, 45% were current smokers with mean CPD of 27.2±40.0. CPY and duration of smoking showed positive linear correlations with percentage monocyte count. Physiologically, CPY was associated with progressive obstruction, hyperinflation, and reduced diffusion capacity (DL CO ). Across the quartiles of smoking, there was an accumulation of radiologic and histologic abnormalities. Anthracosis and emphysema were associated with CPD, while lung cancer, respiratory bronchiolitis (RB), emphysema, and honeycombing were statistically related to duration of smoking. Analysis using consecutive CPY showed associations with lung cancer (≥10 and <30), fibrosis (≥20 and <40), RB (≥50), anthracosis and emphysema (≥10 and onwards). Percentage monocytes correlated with organizing pneumonia (OP), fibrosis, and emphysema. The greater CPY increased mortality across the groups. Significant predictors of mortality included percentage monocyte, anemia, GERD, and reduced DL CO . Conclusion Indices of CS and greater monocyte numbers were associated with endpoints of chronic lung disease suggesting a participation in pathogenesis. Application of these easily available metrics may support a chronology of CS-induced chronic lung injuries. While a relative lesser amount of smoking can be associated with lung cancer and fibrosis, greater CPY increases the risk for emphysema. Monocytosis predicted lung fibrosis and mortality. Duration of smoking may serve as a better marker of monocytosis and associated chronic lung diseases.

Rate of incidental findings on routine preoperative computed tomography for shoulder arthroplasty

“…One significant difference between cohorts identified in this study is that patients with incidental findings on CT were significantly more likely to be current smokers and significantly less likely to be never smokers than patients without incidental findings on CT. This finding is not particularly surprising given established associations between tobacco use and pulmonary pathology [ 19 - 21 ]. However, this is the only demographic factor of those evaluated that demonstrated significant difference between cohorts.…”

Neutrophil-to-Lymphocyte Ratio and Blood Eosinophil Levels As Inflammatory Indicators in Smoker and Non-smoker Young Adult Patients With Chronic Obstructive Pulmonary Disease at a Tertiary Care Hospital

“…The smoking-induced increase in monocytes is associated with a decline in lung functions and is linked with COPD. Monocytes thus can be used as a marker in COPD to predict prognosis [ 21 ].…”

Zero-Carbon and Carbon-Neutral Fuels: A Review of Combustion Products and Cytotoxicity

“…These cells are essential in maintaining immune homeostasis and tolerance [198]. They are the first line of defense against pathogens, contaminants, or inhaled particulate matter and are considered sentinel cells in immune response, responsible for initiating and resolving the immune response to the invading substance [199]. They mediate non-specific immune responses that are strong and quick enough to prevent infection without inducing damaging inflammation [200].…”